From epilepsy studies to a psg sleep study, clinical trials are a hugely important part of our world – and the way that we are able to receive medical treatment. In fact, without the use of findings from clinical research trials, we would be without a great deal of medical knowledge – and the subsequent treatments – that we have become accustomed to. Take, for instance, the case of Hepatitis C. Hepatitis C was once a sometimes deadly disease at worst and a lifelong condition to be managed at best. Once you were diagnosed with Hepatitis C, you had to begin a treatment regimen that would last you the rest of your life. Even still, liver failure was possible, and many people died of Hepatitis C and the subsequent liver failure before they could get a transplant. Thanks to clinical research studies, however, Hepatitis C is an incredibly treatable condition, cured in as many as ninety five percent to ninety six percent of all diagnosed patients in typically no longer than twelve weeks. And for some patients, even twelve weeks is not necessary and they are able to stop the course of treatment for Hepatitis C after only eight weeks – with a clean bill of health.
And clinical research studies have provided new hope in many a terminal illness. Cancer is a prime example, as cancer is one of the most feared illnesses of the modern world, striking both those who have risk factors and those who did not – but developed a type of cancer (or even more types of cancer) anyway. Because there is still so much that we do not know about cancer and how to treat it so that we can completely eradicate it with no chance of it returning (or at least very slim and minute one), we must conduct clinical research trails to fully expand our knowledge of cancer as much as we possibly can. For instance, we have found that, taking chemo and radiation treatments out of the picture, a typical clinical trial has a probability of success of just more than twenty percent, while oncology drugs alone have a success rate that is, unfortunately, lower than five percent. So it is clear to see how and why clinical trials have brought hope to many cancer patients all throughout the United States and even in the world as a whole.
Though epilepsy is typically not a fatal illness, epilepsy studies have brought a similar hope to patients who suffer from the condition. Epilepsy studies have lead to new breakthroughs, and many people believe that the epilepsy studies that have been conducted have been hugely influential in the scientific and medical strides that have been able to have been made. And it goes further than epilepsy studies, with everything from a paid depression study to diabetes clinical trials. And all these clinical trials, epilepsy studies included, typically follow the same pattern.
First, there is the phase 1 clinical trial. A phase 1 clinical trial is geared at finding out the safety of the drug or the treatment when it is used on humans. A phase 1 clinical trial is typically smaller than the phase 2 clinical trial, as well as shorter. The phase 2 clinical trial, which can last for as long as two years is focused on testing the effectiveness of the drug or of the treatment. Finally, once the phase 2 clinical trial is completed, the phase 3 clinical trial tests both the safety of the drug or treatment as well as the effectiveness of it on a large scale. The final segment of the overall clinical trial, the phase 4 clinical trial, tests long term usage and safety.
From epilepsy studies to studies regarding oncology treatments, clinical research trials are hugely important and influential to the medical community – as well as to each and every one of our lives. After all, without clinical trials, many lives would not have been able to have been saved, and many people would be living a lower quality of life.